Investing
Published September 23, 2026
NeuroThera files patents for psychedelic drug combinations - Investing.com
Read the full story at Investing
(TSXV:NTLX) has published three U.S. patent applications covering combinations of psychedelic compounds with palmitoylethanolamide (PEA) technology,.
Surfaced by 2 Google Alerts
- Psychedelics
- Psychedelic press release